Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for PD, -20
Most Correlated Studies
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
- L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens
- L1000 CMAP - Breast adenocarcinoma SKBR3 cells treated with small molecule perturbagens
Most Relevant Literature
- Universal health coverage: a commitment to essential surgical, obstetric, and anesthesia care, World…
- Development and validation of the Decisional Balance Scale for problematic Prescription Drug use (DB…
- The system uranium-palladium-boron with U(2.5)Pd(20.5)B(6), a new heavy fermion compound.
- Microstructural white matter changes underlying speech deficits in Parkinson's disease.
- Results of Unilateral Lateral Rectus Recession Surgery in 15 - 30 PD Intermittent Exotropia.
Most Relevant Clinical Trials
- Study of ADI-PEG 20 in Patients With Relapsed Sensitive or Refractory Small Cell Lung Cancer
- Study of ADI-PEG 20 in Patients With Advanced Melanoma
- Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors
- Study ADI-PEG 20 Plus Pembrolizumab in Advanced Solid Cancers
- MIRT and Rotigotine in the Early Stage of PD
